Cite
FDG-PET and diffusion-weighted MRI in head-and-neck cancer patients: Implications for dose painting
MLA
Jeroen B. van de Kamer, et al. “FDG-PET and Diffusion-Weighted MRI in Head-and-Neck Cancer Patients: Implications for Dose Painting.” Radiotherapy and Oncology, vol. 106, Feb. 2013, pp. 250–54. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....049dead0da6b1346cb58309a48c7342c&authtype=sso&custid=ns315887.
APA
Jeroen B. van de Kamer, Corine van Vliet-Vroegindeweij, Uulke A. van der Heide, Olga Hamming-Vrieze, Wouter V. Vogel, A.L. Wolf, & Antonetta C. Houweling. (2013). FDG-PET and diffusion-weighted MRI in head-and-neck cancer patients: Implications for dose painting. Radiotherapy and Oncology, 106, 250–254.
Chicago
Jeroen B. van de Kamer, Corine van Vliet-Vroegindeweij, Uulke A. van der Heide, Olga Hamming-Vrieze, Wouter V. Vogel, A.L. Wolf, and Antonetta C. Houweling. 2013. “FDG-PET and Diffusion-Weighted MRI in Head-and-Neck Cancer Patients: Implications for Dose Painting.” Radiotherapy and Oncology 106 (February): 250–54. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....049dead0da6b1346cb58309a48c7342c&authtype=sso&custid=ns315887.